No Data
No Data
No Data
No Data
No Data
Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets
SAN FRANCISCO, May 2, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter 2024 on Thursday, May 9, 2024, after the close of U.S.-based fin
NektarMay 2 00:00 ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersCyclacel Pharmaceuticals (NASDAQ:CYCC) stock moved upwards by 50.0% to $2.04 during Tuesday's pre-market session. The company's market cap stands at $2.6 million. GeneDx Hldgs (NASDAQ:WGS) shar
BenzingaApr 30 08:06 ET
NK Cell Therapies Pipeline Report 2024: Insights on 80+ Companies and 100+ Pipeline Drugs, Including ALECSAT (CytoVac), NKTR-214/Bempegaldesleukin (Nektar Therapeutics), and Monalizumab (Innate Pharma)
Yahoo FinanceApr 26 04:12 ET
Express News | Nektar Therapeutics:Received Letter From Nasdaq Notifying Co It Regained Compliance With Minimum Bid Price Requirement for Continued Listing on Nasdaq
Moomoo 24/7Apr 17 17:06 ET
Express News | Nektar Therapeutics Shares Hit Session Low With Volume Pickup, Last Down 8.4% at $1.53
Moomoo 24/7Apr 15 14:59 ET
NKTR, VERU and EGIO Among Mid-day Movers
Seeking AlphaApr 11 12:55 ET
No Data
No Data